Single-shot pulsed field ablation for complex atrial arrhythmias :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Novel catheter demonstrates feasibility of non-PV ablation using pulsed field technology

Atrial fibrillation Atrial fibrillation
Atrial fibrillation Atrial fibrillation

What's new?

VARIPULSE™ enables effective pulmonary vein isolation and extensive non-pulmonary vein ablation, achieving atrial flutter termination in 96% of cases without major complications.

A new clinical experience highlights the expanding role of pulsed field ablation (PFA) using the VARIPULSE™ variable-loop circular catheter, demonstrating not only effective pulmonary vein isolation (PVI) but also successful mapping and ablation of complex non-pulmonary vein (non-PV) targets in atrial fibrillation (AF).

In this retrospective analysis, 60 patients with paroxysmal or persistent AF underwent catheter ablation using the fully integrated VARIPULSE™ system within a three-dimensional mapping platform.

  • Mean age: 67.15 ± 9.01 years
  • Female patients: 25 (41.6%)
  • Persistent AF: 34 patients (60%)
  • Atrial flutter at index procedure: 6 patients (10%)

PVI using PFA was performed in all patients, following protocol-driven strategy. A substantial proportion of patients required additional substrate modification beyond PVI:

  • Non-PV ablation sites treated: 76.7% of patients
  • Posterior wall isolation: 25 patients (41.7%)
  • Anterior line ablation: 16 patients (26.7%)
  • Roof line ablation: 9 patients (15%)
  • Cavotricuspid isthmus ablation: 11 patients (18.3%)
  • Superior vena cava isolation: 2 patients (3.3%)

Notably, 27 patients developed atrial flutters during the index procedure, which were mapped and ablated using the VARIPULSE catheter. Termination of atrial flutter was achieved in all but one patient, underscoring the platform’s mapping precision and ablation effectiveness in complex atrial arrhythmias. Importantly, no major complications were detected, supporting the safety profile of PFA technology even when extended to non-PV targets and atypical atrial flutter circuits.

While PFA is increasingly adopted for PVI, evidence regarding its application to non-PV substrates has remained limited. This study demonstrates that the VARIPULSE™ PFA catheter enables:

  • Effective PVI
  • Precise mapping of complex atrial substrates
  • Successful ablation of atypical atrial flutter
  • Safe delivery of empiric linear lesions when clinically indicated

Source:

Journal of Clinical Medicine

Article:

Single-Center Real World Experience with the VARIPULSE Platform for Pulsed Field Ablation of Atrial Fibrillation, Atrial Flutter, and Redo Procedures

Authors:

Nizar Andria et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: